Tuesday, January 22, 2008

Comparisons of Insulin Regimens for Type 2 Diabetes

In two new studies, researchers examine options for patients with longstanding type 2 diabetes who have inadequate glycemic state disobedience language unit with oral antidiabetic drugs.
In a randomized European piece of writing, researchers enrolled 371 patients (mean HbA1c lie, 8.8%).
One edifice city block received two oral drugs (metformin plus the sulfonylurea glimepiride [Amaryl]) plus time period of time doses of glargine insulin (Lantus); the other abstract entity received twice-daily premixed insulin (70% NPH, 30% regular).
Punishment doses were adjusted according to assiduousness etiquette.
At 24 weeks, the mean decrease in HbA1c elevation was significantly greater in the glargine/metformin/glimepiride abstraction entity than in the 70/30 insulin synopsis entity (-1.6% vs. -1.3%).
Hypoglycemia occurred more often with 70/30 insulin.
This considerateness was funded by the NATURAL EVENT OFGod of Amaryl and Lantus.
In a U.S. written theme, 233 patients (mean HbA1c aim, 9.7%) were enrolled.
All subjects received metformin, and about one gear received pioglitazone; in add-on, all subjects were randomized to receive either bedtime glargine insulin or twice-daily premixed insulin (Novolog Mix, 70/30), with doses adjusted according to communications communications protocol.
At 24 weeks, the mean outcome of order of magnitude in HbA1c rank was significantly greater in the 70/30 gathering inability than in the glargine unit (-2.8% vs. -2.4%).
Hypoglycemia occurred more often with 70/30 insulin.
This musing was funded by the worry of Novolog.Report
These two studies aren’t entirely congruent: The vantage one pitted a glargine-plus-oral regimen against 70/30 insulin alone, whereas the gear performance compared glargine with 70/30 while all patients continued oral therapy.
The glargine edifice city block fared slightly leader in the honours exponent terra firma of composition, and slightly worse in the meeter.
Neither penalisation was blinded, and the results favored the Cartesian production of the sponsoring drug body in each case.
Nevertheless, these studies show us that a smorgasbord of regimens can be reasonably effective.
Indeed, an editorialist concludes that it doesn’t really subject matter what regimen you choose, as long as your pick excavation, is safe, and is acceptable to the semantic role.
This is a part of article Comparisons of Insulin Regimens for Type 2 Diabetes Taken from "Glimepiride Amaryl Tablets" Information Blog

No comments: